Z71.6 Counselling for tobacco use disorder
This New Zealand Coding Convention was related to the reporting requirement previously aligned with the Health Target ‘Better help for smokers to quit’. This reporting requirement is now aligned with the DHB Non-Financial Monitoring Framework and Performance Measure ‘Better help for smokers to quit in public hospitals’.
Z71.6 Counselling for tobacco use disorder is assigned as an additional diagnosis when there is evidence within the clinical record of one or more of the following:
- Brief advice to quit including documentation where advice and/or treatment has been offered but declined by patient.
- Charting or prescribing of the following pharmacotherapies when used for smoking cessation and/or temporary abstinence purposes for public hospital inpatients.
- Nicotine replacement therapy (transdermal patch, gum, lozenge, inhaler, microtab)
- Varenicline (Champix)
- Bupropion (Zyban)
- Nortriptyline (documented to aid smoking cessation).
- A referral made to a smoking cessation specialist or programme (inpatient or outpatient). This may include any of the following:
- Hospital Smokefree Team
- Aukati Kai Paipa
- Other local cessation provider.
- A referral to General Practitioner or Practice Nurse for follow-up of smoking or tobacco dependence, or smoking cessation, post-discharge from hospital.
Clinical coders are advised to:
- Include free text in the code description for Z71.6 Counselling for tobacco use disorder, see examples:
- Z71.6 Counselling for tobacco use – offered NRT – declined
- Z71.6 Counselling for tobacco use – charted NRT
- Z71.6 Counselling for tobacco use – referred to Quitline
- Z71.6 Counselling for tobacco use – advice given
- contact their Smokefree Coordinators for assistance and support to improve documentation within the clinical record.